Journal Article Summary
The article investigates the potential anticancer effects of paroxetine, a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety, specifically in human colon cancer cells. This research is significant because colorectal cancer (CRC) remains a major health challenge, being one of the most prevalent cancers and a leading cause of cancer-related deaths worldwide. The study aims to explore whether repurposing paroxetine could provide a new therapeutic option for CRC, especially given the limitations of existing treatments and the rising interest in drug repositioning in oncology.
The researchers conducted experiments using two human colorectal cancer cell lines, HCT116 and HT29, to assess the effects of paroxetine on cell viability, apoptosis, and tumor growth. They found that paroxetine reduced cell viability in a dose-dependent manner, induced apoptosis, and inhibited both colony and spheroid formation in these cancer cells. Additionally, in vivo studies using athymic nude mice demonstrated that paroxetine significantly suppressed tumor growth in mice implanted with HT29 cells, suggesting its potential effectiveness as an anticancer agent.
However, the study has limitations, including the need for further research to confirm the findings and understand the precise mechanisms by which paroxetine exerts its effects. Patients should be cautious and consult healthcare professionals before considering any changes to their treatment plans, as the use of paroxetine for cancer treatment is not yet established in clinical practice. Discussing this research with a healthcare provider can help patients understand the implications and explore all available treatment options for colorectal cancer.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Jang Won‐Jun, Jung Sung Keun, Vo Tam Thuy Lu, Jeong Chul‐Ho. Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3. Journal of Cellular and Molecular Medicine 2018. DOI: 10.1111/jcmm.14011. PMID: 30421568. PMCID: PMC6349215.
Featured Pill Pals Product
Paroxetine 10 mg Tablets --- 30 Count --- Generic for Paxil --- Zydus Pharma
Paroxetine 10 mg Tablets --- 30 Count --- Generic for Paxil --- Zydus Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
